ROSE fundamentals
Key facts
Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. It operates through the following business segments: Biological Products, Pharmaceutical Products, and Others. The Biological Products segment includes products for reproductive-respiratory complex, brucellosis and carbuncle, clostridial and other vaccines, horses, pneumonia and calve diarrhea, and queratoconjuntivitis. The Pharmaceutical Products segment includes antimastitics, antimicotics-bacteriostatics, endectocides, external antiparasitics, injectable antibiotics, internal antiparasitics, other chemotherapics, and vitamins and minerals. The company was founded by Francisco Conrado Rosenbusch in 1917 and is headquartered in Buenos Aires, Argentina.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Revenue breakdown
Revenue streams and regions a business earns money from
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company